News
The Economic Times
Jan 28, 2026
Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human trials of Eyecyte-RPE
Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell therapy. This treatment aims to address geographic atrophy, a condition causing vision loss. The trials will assess the therapy's safety and effectiveness in a larger patient group.
The Economic Times
Jan 27, 2026
Nivaan Care raises $7 million in funding led by Sorin Investments
The startup will use the funds to expand its clinic network across multiple Indian cities, strengthen its clinical and operating infrastructure, and to enhance its minimally invasive pain management procedures. Founded in 2023, the New Delhi-based company focuses on non-surgical treatment of chronic pain across the body, including back, neck, knee, and other conditions.
The New Indian Express
Jan 8, 2026
BluJ Aerospace: Indian aviation on new altitudes
BluJ Aerospace Private Limited, founded in 2022 and headquartered in Hyderabad, is at the forefront of this transformation, building next-generation VTOL aircraft that redefine how people and cargo move through the air.
2022 All rights reserved
